Retatrutide
20 mg
Retatrutide - Triple Hormone Receptor Agonist
Retatrutide is an investigational compound that represents one of the most advanced approaches in metabolic and weight management medicine to date. What sets it apart from other treatments in its class is its ability to simultaneously activate three distinct hormone receptors GLP-1, GIP, and Glucagon earning it the designation of a triple hormone receptor agonist. By engaging all three pathways at once, Retatrutide targets appetite regulation and metabolism through a more comprehensive and synergistic mechanism than single or dual-receptor treatments.
How It Works - The Three Pathways
GLP-1 (Glucagon-Like Peptide-1)
GLP-1 is a hormone naturally released by the gut in response to eating. It signals the brain to reduce appetite, promotes a feeling of fullness after meals, slows the rate at which the stomach empties, and supports healthy blood sugar regulation by stimulating insulin release. Activating this pathway helps reduce overall caloric intake and supports glycemic control.
GIP (Glucose-Dependent Insulinotropic Polypeptide)
GIP is another gut-derived hormone that works alongside GLP-1 to enhance the body’s insulin response after eating. It also plays a role in fat metabolism and energy storage regulation. The addition of GIP activity is thought to amplify the metabolic benefits of GLP-1 stimulation, contributing to improved body composition outcomes.
Glucagon
Glucagon is a hormone produced by the pancreas that plays a key role in energy expenditure and fat breakdown. By activating glucagon receptors, Retatrutide may increase the number of calories the body burns at rest, promote the breakdown of stored fat for energy, and support liver health by reducing fat accumulation, a meaningful distinction from treatments that target GLP-1 alone.
Potential Benefits
The combined activation of all three receptor pathways positions Retatrutide as a potentially powerful tool for individuals managing obesity, metabolic syndrome, or related conditions. Early clinical research has shown promising results in the areas of:
∙ Significant and sustained weight reduction
∙ Improved blood sugar regulation and insulin sensitivity
∙ Enhanced fat metabolism and energy expenditure
∙ Potential reduction in liver fat accumulation